ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 67 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | – | 364 | -9.9% | 0.00% | – |
| Q3 2018 | $0 | – | 404 | -9.2% | 0.00% | – |
| Q2 2018 | $0 | – | 445 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 445 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 445 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | -50.0% | 445 | -40.3% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 745 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | -33.3% | 745 | +8.3% | 0.00% | – |
| Q4 2016 | $3,000 | 0.0% | 688 | -0.1% | 0.00% | – |
| Q3 2016 | $3,000 | +50.0% | 689 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | -33.3% | 689 | 0.0% | 0.00% | – |
| Q1 2016 | $3,000 | 0.0% | 689 | 0.0% | 0.00% | – |
| Q4 2015 | $3,000 | 0.0% | 689 | 0.0% | 0.00% | – |
| Q3 2015 | $3,000 | -25.0% | 689 | -17.9% | 0.00% | – |
| Q2 2015 | $4,000 | -42.9% | 839 | -9.0% | 0.00% | – |
| Q1 2015 | $7,000 | +250.0% | 922 | +48.2% | 0.00% | – |
| Q4 2014 | $2,000 | – | 622 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 1,641,025 | $7,549,000 | 1.29% |
| Squarepoint Ops LLC | 10,200 | $47,000 | 0.02% |
| DELTEC ASSET MANAGEMENT LLC | 15,000 | $69,000 | 0.02% |
| FIRST NEW YORK SECURITIES LLC /NY | 5,700 | $26,220,000 | 0.01% |
| WEDBUSH SECURITIES INC | 11,033 | $51,000 | 0.01% |
| Allen Investment Management, LLC | 15,524 | $71,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 14,512 | $67,000 | 0.01% |
| A.R.T. Advisors, LLC | 19,216 | $88,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 134,102 | $617,000 | 0.00% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 17,105 | $79,000 | 0.00% |